Supriya Lifescience Limited

644.4

INR
+35.50(+5.83%)
As of November 14, 2024 10:00:00 AM

Supriya Lifescience Limited Share Price Information

24 hour Low and High

Low: 611.2
High: 647.55

All time High

673.55

Price Change 1h

+₹26.75 +4.33%

Price Change 1d

+₹26.75 +4.33%

Price Change 1w

+₹-3.90 +-0.60%

Supriya Lifescience Limited Market Information

Exchange

NSE

Market Cap

5032.99 Cr

About Supriya Lifescience Limited Share

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, anti-malarial products, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, it also offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, the company is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessasion, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic, stem cell transplantation, and anti-migraine. The company was founded in 1987 and is headquartered in Mumbai, India.

Sector

Healthcare

Biotechnology

Employees

about

448

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Supriya Lifescience share price skyrockets 8% to 52-week high: Nearly doubles in a year as Europe sales gain traction | Stock Market News
  • Supriya Lifescience's Stock Price Soars 8.5%, Hits New 52-Week High on Strong Performance
  • Supriya Lifescience Limited (NSE:SUPRIYA) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
  • Supriya Lifescience - Technical picks: Bajaj Auto, Godfrey Phillips among 5 stocks that can rally up to 35% in short-term
  • Our primary goal is to double our revenue, enter higher-margin niche segments and increase footprint: Dr. Saloni Wagh, Director, Supriya Lifescience Ltd.

FAQs

Supriya Lifescience Limited

644.4

INR
+35.50(+5.83%)
As of November 14, 2024 10:00:00 AM

Supriya Lifescience Limited Share Price Information

24 hour Low and High

Low: 611.2
High: 647.55

All time High

673.55

Price Change 1h

+₹26.75 +4.33%

Price Change 1d

+₹26.75 +4.33%

Price Change 1w

+₹-3.90 +-0.60%

Supriya Lifescience Limited Market Information

Exchange

NSE

Market Cap

5032.99 Cr

About Supriya Lifescience Limited Share

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, anti-malarial products, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, it also offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, the company is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessasion, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic, stem cell transplantation, and anti-migraine. The company was founded in 1987 and is headquartered in Mumbai, India.

Sector

Healthcare

Biotechnology

Employees

about

448

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Supriya Lifescience share price skyrockets 8% to 52-week high: Nearly doubles in a year as Europe sales gain traction | Stock Market News
  • Supriya Lifescience's Stock Price Soars 8.5%, Hits New 52-Week High on Strong Performance
  • Supriya Lifescience Limited (NSE:SUPRIYA) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
  • Supriya Lifescience - Technical picks: Bajaj Auto, Godfrey Phillips among 5 stocks that can rally up to 35% in short-term
  • Our primary goal is to double our revenue, enter higher-margin niche segments and increase footprint: Dr. Saloni Wagh, Director, Supriya Lifescience Ltd.

FAQs